|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 27, 2017 ) According to the report Europe Nuclear Medicine Radiopharmaceuticals Market, published by Market Data Forecast, the Europe market is projected to reach USD 1.8 billion by 2021, at a CAGR of 11.4% from 2016 to 2021.
Nuclear medicine is studied or analysed under the field of Molecular Imaging, which comprises utilization of a tiny measure of radioactive material (radiopharmaceuticals) to investigate and cure ailments.
Get a comprehensive overview of the Europe Nuclear Medicine Radiopharmaceuticals Market: http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/
Europe Nuclear Medicine Radiopharmaceuticals Market: Drivers & Restraints
Increasing number of occurrences of chronic diseases, for example, cancer and cardiac diseases, immense technological headways, rising demand for SPECT and PET applications alongside the augmenting public awareness for healthcare are the key factors propelling the development of Radiopharmaceuticals market. Likewise, Integration of X ray tomography (CT) into SPECT has as of late developed as an outstanding diagnostic instrument in medical imaging and is likely to be a driving agent for the development of the market. Stringent administrative framework and reimbursement issues are the key elements are inhibiting the development of the market. Notwithstanding the above factors lesser half-life of radiopharmaceuticals and competition from conventional diagnostic methods are primarily the key elements controlling the North America nuclear medicine Radioisotopes market.
Get accurate market forecast and analysis on the Europe Nuclear Medicine Radiopharmaceuticals Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/request-sample
Europe Nuclear Medicine Radiopharmaceuticals Market: Segmentation
By Diagnostic radioisotopes
• SPECT (Technetium-99m, Thallium-201 Gallium-67, Iodine)
• PET (Fluorine-18, Rubidium-82)
By Therapeutic radioisotopes
• Beta emitters (Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177)
• Alpha Emitters (Radium-223)
• Brachytherapy (Cesium-131, Iodine-125, Palladium-103, Iridium-192)
By Application
• cardiology
• lymphoma
• thyroid
• neurology oncology
• others
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/customize-report
Europe Nuclear Medicine Radiopharmaceuticals Market: Overview
Increasing utilization of SPECT and PET in medical diagnostics, rising awareness among individuals about radiopharmaceuticals, and ready accessibility of radiopharmaceuticals are few of the primary factors fuelling the development of the market. However, lesser half-life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are a few limitations for the nuclear medicine market growth.
Radiopharmaceuticals market is commanded by diagnostic radioisotopes with a market portion of 90 % although the therapeutic radioisotopes contribute a minor portion of around 10% of the market. The F-18 market is primarily abetted by F-18 FDG tracers although this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The reliable clinical outcomes of these tracers have been gaining the confidence of major research institutes and PET isotope players. Ga-68 and Rb-82 are two new potential isotopes in the PET diagnostic market, making sure the high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising signs for the future PET radioisotopes market.
Europe Nuclear Medicine Radiopharmaceuticals Market: Region-wise Outlook
In addition, by geography, the European Market is categorized into various regions namely UK, Spain, Italy, Germany and France.
Key Questions Answered
• What is the current and future Europe Nuclear Medicine Radiopharmaceuticals market outlook in Europe? What trends are affecting the European market?
• What is the competitive landscape and market share of major players in the Europe Nuclear Medicine Radiopharmaceuticals space in Europe?
• What are the key, high growth markets that Europe Nuclear Medicine Radiopharmaceuticals manufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the Europe Nuclear Medicine Radiopharmaceuticals currently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of Europe Nuclear Medicine Radiopharmaceuticals?
• What are the challenges and barriers that have hindered widespread adoption of Europe Nuclear Medicine Radiopharmaceuticals?
Europe Nuclear Medicine Radiopharmaceuticals Market: Key Players
Some of the key players dominating the Europe nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.
Reasons to buy Europe Nuclear Medicine Radiopharmaceuticals Market Report:
• regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
• A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
